Similarly, in the FTC versus normal and benign tissue comparison, the genes CDKN1C, CREB1, FOS, HSPA5, and JUN were also significantly downregulated, corroborating the trends observed in our experimental dataset. This evidence concerns the gene CREB1 and thyroid cancer, nonmedullary, 2.